Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model

Charles F. LeMaistre, Kara K. Wacker, Luke P. Akard, A. Samer Al-Homsi, Dennis A. Gastineau, Kamar Godder, Michael Lill, George B. Selby, Amir Steinberg, Judy M. Anderson, Alan K. Leahigh, Phyllis I. Warkentin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Foundation for the Accreditation of Cellular Therapy (FACT). These organizations have addressed 2 of the 9 elements identified by the National Quality Strategy (NQS) for achieving better health care, more affordable care, and healthy people and communities: a registry that promotes improvement of care and accreditation based on quality standards. More recently, a federally mandated database in the United States addresses the third element of the NQS: public reporting of treatment results. Here we describe the current process by which FACT incorporates patient outcomes reported by the CIBMTR into standards for accreditation, the requirements for accredited programs with performance below expected outcomes to maintain accreditation, and preliminary findings of an assessment of corrective action plans intended to improve outcomes.

Original languageEnglish (US)
Pages (from-to)2243-2250
Number of pages8
JournalBiology of Blood and Marrow Transplantation
Volume25
Issue number11
DOIs
StatePublished - Nov 2019

Fingerprint

Accreditation
Bone Marrow
Organizations
Transplants
Therapeutics
Research
Registries
Transplantation
Databases
Delivery of Health Care

Keywords

  • Accreditation
  • Publicly reported outcomes
  • Quality

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Integration of Publicly Reported Center Outcomes into Standards and Accreditation : The FACT Model. / LeMaistre, Charles F.; Wacker, Kara K.; Akard, Luke P.; Al-Homsi, A. Samer; Gastineau, Dennis A.; Godder, Kamar; Lill, Michael; Selby, George B.; Steinberg, Amir; Anderson, Judy M.; Leahigh, Alan K.; Warkentin, Phyllis I.

In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 11, 11.2019, p. 2243-2250.

Research output: Contribution to journalArticle

LeMaistre, CF, Wacker, KK, Akard, LP, Al-Homsi, AS, Gastineau, DA, Godder, K, Lill, M, Selby, GB, Steinberg, A, Anderson, JM, Leahigh, AK & Warkentin, PI 2019, 'Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model', Biology of Blood and Marrow Transplantation, vol. 25, no. 11, pp. 2243-2250. https://doi.org/10.1016/j.bbmt.2019.06.035
LeMaistre, Charles F. ; Wacker, Kara K. ; Akard, Luke P. ; Al-Homsi, A. Samer ; Gastineau, Dennis A. ; Godder, Kamar ; Lill, Michael ; Selby, George B. ; Steinberg, Amir ; Anderson, Judy M. ; Leahigh, Alan K. ; Warkentin, Phyllis I. / Integration of Publicly Reported Center Outcomes into Standards and Accreditation : The FACT Model. In: Biology of Blood and Marrow Transplantation. 2019 ; Vol. 25, No. 11. pp. 2243-2250.
@article{65519f393abb4b64a1b617ea6258d0c1,
title = "Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model",
abstract = "The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Foundation for the Accreditation of Cellular Therapy (FACT). These organizations have addressed 2 of the 9 elements identified by the National Quality Strategy (NQS) for achieving better health care, more affordable care, and healthy people and communities: a registry that promotes improvement of care and accreditation based on quality standards. More recently, a federally mandated database in the United States addresses the third element of the NQS: public reporting of treatment results. Here we describe the current process by which FACT incorporates patient outcomes reported by the CIBMTR into standards for accreditation, the requirements for accredited programs with performance below expected outcomes to maintain accreditation, and preliminary findings of an assessment of corrective action plans intended to improve outcomes.",
keywords = "Accreditation, Publicly reported outcomes, Quality",
author = "LeMaistre, {Charles F.} and Wacker, {Kara K.} and Akard, {Luke P.} and Al-Homsi, {A. Samer} and Gastineau, {Dennis A.} and Kamar Godder and Michael Lill and Selby, {George B.} and Amir Steinberg and Anderson, {Judy M.} and Leahigh, {Alan K.} and Warkentin, {Phyllis I.}",
year = "2019",
month = "11",
doi = "10.1016/j.bbmt.2019.06.035",
language = "English (US)",
volume = "25",
pages = "2243--2250",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Integration of Publicly Reported Center Outcomes into Standards and Accreditation

T2 - The FACT Model

AU - LeMaistre, Charles F.

AU - Wacker, Kara K.

AU - Akard, Luke P.

AU - Al-Homsi, A. Samer

AU - Gastineau, Dennis A.

AU - Godder, Kamar

AU - Lill, Michael

AU - Selby, George B.

AU - Steinberg, Amir

AU - Anderson, Judy M.

AU - Leahigh, Alan K.

AU - Warkentin, Phyllis I.

PY - 2019/11

Y1 - 2019/11

N2 - The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Foundation for the Accreditation of Cellular Therapy (FACT). These organizations have addressed 2 of the 9 elements identified by the National Quality Strategy (NQS) for achieving better health care, more affordable care, and healthy people and communities: a registry that promotes improvement of care and accreditation based on quality standards. More recently, a federally mandated database in the United States addresses the third element of the NQS: public reporting of treatment results. Here we describe the current process by which FACT incorporates patient outcomes reported by the CIBMTR into standards for accreditation, the requirements for accredited programs with performance below expected outcomes to maintain accreditation, and preliminary findings of an assessment of corrective action plans intended to improve outcomes.

AB - The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Foundation for the Accreditation of Cellular Therapy (FACT). These organizations have addressed 2 of the 9 elements identified by the National Quality Strategy (NQS) for achieving better health care, more affordable care, and healthy people and communities: a registry that promotes improvement of care and accreditation based on quality standards. More recently, a federally mandated database in the United States addresses the third element of the NQS: public reporting of treatment results. Here we describe the current process by which FACT incorporates patient outcomes reported by the CIBMTR into standards for accreditation, the requirements for accredited programs with performance below expected outcomes to maintain accreditation, and preliminary findings of an assessment of corrective action plans intended to improve outcomes.

KW - Accreditation

KW - Publicly reported outcomes

KW - Quality

UR - http://www.scopus.com/inward/record.url?scp=85074586872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074586872&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2019.06.035

DO - 10.1016/j.bbmt.2019.06.035

M3 - Article

C2 - 31284070

AN - SCOPUS:85074586872

VL - 25

SP - 2243

EP - 2250

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 11

ER -